Company · Toronto, Ontario, Canada
Sanofi-Aventis Canada Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 235
- 99 authorized now
- Natural health products
- 3
- 0 active licences
- Medical device licences
- 10
- 1 active
- Notices of Compliance
- 479
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ADMELOG | 02469898 | Marketed | |
| ADMELOG | 02469901 | Marketed | |
| ADMELOG SOLOSTAR | 02469871 | Marketed | |
| ALDURAZYME | 02254506 | Marketed | |
| ALPROLIX | 02422913 | Marketed | |
| ALPROLIX | 02422921 | Marketed | |
| ALPROLIX | 02422948 | Marketed | |
| ALPROLIX | 02422956 | Marketed | |
| ALTUVIIIO | 02447967 | Marketed | |
| ALTUVIIIO | 02448122 | Marketed | |
| ALTUVIIIO | 02448130 | Marketed | |
| ALTUVIIIO | 02448149 | Marketed | |
| ALTUVIIIO | 02448157 | Marketed | |
| APIDRA | 02279460 | Marketed | |
| APIDRA | 02279479 | Marketed | |
| APIDRA | 02294346 | Marketed | |
| ARAVA | 02241888 | Marketed | |
| ARAVA | 02241889 | Marketed | |
| AVALIDE | 02241818 | Marketed | |
| AVALIDE | 02241819 | Marketed | |
| AVAPRO | 02237924 | Marketed | |
| AVAPRO | 02237925 | Marketed | |
| CERDELGA | 02463261 | Marketed | |
| CEREZYME | 02241751 | Marketed | |
| CLOLAR | 02330407 | Marketed | |
| CYCLOMEN | 02018160 | Marketed | |
| CYCLOMEN | 02018152 | Marketed | |
| DUPIXENT | 02470365 | Marketed | |
| DUPIXENT | 02492504 | Marketed | |
| DUPIXENT | 02510049 | Marketed | |
| DUPIXENT | 02524252 | Marketed | |
| ELOCTATE | 02430290 | Marketed | |
| ELOCTATE | 02430304 | Marketed | |
| ELOCTATE | 02430312 | Marketed | |
| ELOCTATE | 02430320 | Marketed | |
| ELOCTATE | 02430339 | Marketed | |
| ELOCTATE | 02430347 | Marketed | |
| ELOCTATE | 02430355 | Marketed | |
| FABRAZYME | 02248965 | Marketed | |
| FABRAZYME | 02248966 | Marketed | |
| FASTURTEC | 02248416 | Marketed | |
| FERRLECIT | 02243333 | Marketed | |
| FLAGYSTATIN | 01926829 | Marketed | |
| FLUDARA | 02246226 | Marketed | |
| GLUCOPHAGE | 02099233 | Marketed | |
| IMOVANE | 01926799 | Marketed | |
| KAYEXALATE | 02026961 | Marketed | |
| KEVZARA | 02460548 | Marketed | |
| KEVZARA | 02472961 | Marketed | |
| KEVZARA | 02472988 | Marketed | |
| LANTUS | 02245689 | Marketed | |
| LANTUS | 02251930 | Marketed | |
| LANTUS | 02294338 | Marketed | |
| LASIX ORAL SOLUTION | 02224720 | Marketed | |
| LASIX SPECIAL | 02224755 | Marketed | |
| LEMTRADA | 02418320 | Marketed | |
| LOVENOX | 02012472 | Marketed | |
| LOVENOX | 02236883 | Marketed | |
| LOVENOX | 02378426 | Marketed | |
| LOVENOX | 02378434 | Marketed | |
| LOVENOX | 02378442 | Marketed | |
| LOVENOX HP | 02242692 | Marketed | |
| LOVENOX HP | 02378469 | Marketed | |
| LOVENOX WITH PRESERVATIVE 300MG/3ML | 02236564 | Marketed | |
| MABCAMPATH | 02290960 | Marketed | |
| MERSYNDOL WITH CODEINE | 02047667 | Marketed | |
| MULTAQ | 02330989 | Marketed | |
| MYOZYME | 02284863 | Marketed | |
| NEXVIAZYME | 02522365 | Marketed | |
| PLAQUENIL | 02017709 | Marketed | |
| PLAVIX | 02238682 | Marketed | |
| PRALUENT | 02453819 | Marketed | |
| PRALUENT | 02453835 | Marketed | |
| PRALUENT | 02547732 | Marketed | |
| PRIMAQUINE | 02017776 | Marketed | |
| RENAGEL | 02244310 | Marketed | |
| RENVELA | 02354586 | Marketed | |
| RESONIUM CALCIUM | 02017741 | Marketed | |
| REZUROCK | 02526115 | Marketed | |
| RILUTEK | 02242763 | Marketed | |
| SARCLISA | 02498235 | Marketed | |
| SARCLISA | 02498243 | Marketed | |
| SOLIQUA | 02478293 | Marketed | |
| THYMOGLOBULIN | 02246805 | Marketed | |
| THYROGEN | 02246016 | Marketed | |
| TOUJEO DOUBLESTAR | 02493373 | Marketed | |
| TOUJEO SOLOSTAR | 02441829 | Marketed | |
| TRURAPI | 02506564 | Marketed | |
| TRURAPI | 02506572 | Marketed | |
| TRURAPI | 02529254 | Marketed | |
| TZIELD | 02557347 | Marketed | |
| XATRAL | 02245565 | Marketed | |
| XENPOZYME | 02545721 | Marketed | |
| ZAROXOLYN | 00888400 | Marketed | |
| ALPROLIX | 02422905 | Approved | |
| ALPROLIX | 02474034 | Approved | |
| ALTUVIIIO | 02448114 | Approved | |
| SARCLISA SC | 02571498 | Approved | |
| XENPOZYME | 02545713 | Approved | |
| ADLYXINE | 02464276 | Cancelled Post Market | |
| ADLYXINE | 02464284 | Cancelled Post Market | |
| ADLYXINE | 02464349 | Cancelled Post Market | |
| ALTACE PLUS FELODIPINE 2.5MG + 2.5MG | 02240307 | Cancelled Post Market | |
| ALTACE PLUS FELODIPINE 5MG + 5MG | 02240306 | Cancelled Post Market | |
| AMARYL | 02245272 | Cancelled Post Market | |
| AMARYL | 02245273 | Cancelled Post Market | |
| AMARYL | 02245274 | Cancelled Post Market | |
| ANZEMET | 02231378 | Cancelled Post Market | |
| ANZEMET | 02231379 | Cancelled Post Market | |
| ANZEMET INJECTION 20 MG/ML | 02231380 | Cancelled Post Market | |
| APIDRA | 02279487 | Cancelled Pre Market | |
| ARAVA | 02241890 | Cancelled Post Market | |
| ATROVENT NASAL SPRAY | 02163705 | Cancelled Post Market | |
| ATROVENT NASAL SPRAY | 02163713 | Cancelled Post Market | |
| AUBAGIO | 02416328 | Cancelled Post Market | |
| AVALIDE | 02280213 | Cancelled Post Market | |
| AVAPRO | 02237923 | Cancelled Post Market | |
| CABLIVI | 02496194 | Cancelled Post Market | |
| CALCIMAR | 01926691 | Cancelled Post Market | |
| CLAFORAN - PWS INJ 1.0G/VIAL | 02225093 | Cancelled Post Market | |
| CLAFORAN - PWS INJ 2.0G/VIAL | 02225107 | Cancelled Post Market | |
| CLAFORAN - PWS INJ 500MG/VIAL | 02225085 | Cancelled Post Market | |
| CLOMID | 02091879 | Cancelled Post Market | |
| CONDYLINE | 01945149 | Cancelled Post Market | |
| CYCLOMEN | 02018144 | Cancelled Post Market | |
| DEMEROL | 02138018 | Cancelled Post Market | |
| DIABETA | 02224550 | Cancelled Post Market | |
| DIABETA | 02224569 | Cancelled Post Market | |
| DUPIXENT | 02526190 | Cancelled Pre Market | |
| ELOXATIN | 02296268 | Cancelled Post Market | |
| ELOXATIN | 02296276 | Cancelled Post Market | |
| ELOXATIN | 02296284 | Cancelled Post Market | |
| FASTURTEC | 02271397 | Cancelled Pre Market | |
| FLAGYL | 01926853 | Cancelled Pre Market | |
| FLAGYL | 01926861 | Cancelled Post Market | |
| FLAGYSTATIN | 01926845 | Cancelled Post Market | |
| FLUOTIC | 02099225 | Cancelled Post Market | |
| GLUCOPHAGE | 02162849 | Cancelled Post Market | |
| GLUCOPHAGE | 02446065 | Cancelled Pre Market | |
| IMOVANE | 02216167 | Cancelled Post Market | |
| INTAL INHALER | 00555649 | Cancelled Post Market | |
| IONAMIN | 00891762 | Cancelled Post Market | |
| IONAMIN | 00891770 | Cancelled Post Market | |
| IVADAL | 02205971 | Cancelled Pre Market | |
| IVADAL | 02205998 | Cancelled Pre Market | |
| JEVTANA | 02369524 | Cancelled Post Market | |
| KETEK | 02247520 | Cancelled Post Market | |
| KEVZARA | 02460521 | Cancelled Post Market | |
| LANTUS | 02276410 | Cancelled Pre Market | |
| LANTUS | 02280418 | Cancelled Pre Market | |
| LARGACTIL 100 | 01929976 | Cancelled Post Market | |
| LARGACTIL 25 | 01929968 | Cancelled Post Market | |
| LARGACTIL DROPS 40MG/ML | 01929992 | Cancelled Post Market | |
| LARGACTIL SUP 100MG | 01930001 | Cancelled Post Market | |
| LASIX | 02224690 | Cancelled Post Market | |
| LASIX | 02224704 | Cancelled Post Market | |
| LIBTAYO | 02487152 | Cancelled Post Market | |
| LORELCO | 02091909 | Cancelled Post Market | |
| LOVENOX HP | 02378450 | Cancelled Pre Market | |
| MOZOBIL | 02377225 | Cancelled Post Market | |
| MYOCHRYSINE | 01927604 | Cancelled Post Market | |
| MYOCHRYSINE | 01927612 | Cancelled Post Market | |
| MYOCHRYSINE | 01927620 | Cancelled Post Market | |
| NASACORT | 01913328 | Cancelled Post Market | |
| NEGGRAM | 02017687 | Cancelled Post Market | |
| NORPRAMIN 25MG TAB | 02099128 | Cancelled Post Market | |
| NORPRAMIN 50MG TAB | 02099136 | Cancelled Post Market | |
| NOVAHISTEX DH | 02049481 | Cancelled Post Market | |
| NOVAHISTINE DH | 02049473 | Cancelled Post Market | |
| NOZINAN | 01927655 | Cancelled Post Market | |
| NOZINAN | 01927663 | Cancelled Post Market | |
| NOZINAN | 01927671 | Cancelled Post Market | |
| NOZINAN | 01927728 | Cancelled Post Market | |
| ORELOX | 02226847 | Cancelled Pre Market | |
| ORIFER F | 02103044 | Cancelled Post Market | |
| PEDIAPRED | 02230619 | Cancelled Post Market | |
| PHISOHEX | 02017733 | Cancelled Post Market | |
| PIPORTIL L4 | 01926675 | Cancelled Post Market | |
| PIPORTIL L4 | 01926667 | Cancelled Post Market | |
| PLAVIX | 02330555 | Cancelled Post Market | |
| PRALUENT | 02453754 | Cancelled Post Market | |
| PRALUENT | 02453762 | Cancelled Post Market | |
| RAMACE | 02248884 | Cancelled Pre Market | |
| RAMACE | 02248885 | Cancelled Pre Market | |
| RAMACE | 02248886 | Cancelled Pre Market | |
| RAMACE | 02248887 | Cancelled Pre Market | |
| RENEDIL | 02221985 | Cancelled Post Market | |
| RENEDIL | 02221993 | Cancelled Post Market | |
| RENEDIL | 02222000 | Cancelled Post Market | |
| RENVELA | 02485559 | Cancelled Post Market | |
| RENVELA | 02485567 | Cancelled Post Market | |
| RHODIS | 00761699 | Cancelled Post Market | |
| RHODIS EC | 00761672 | Cancelled Post Market | |
| RHODIS EC | 00761680 | Cancelled Post Market | |
| RHOTRAL 100 | 01910140 | Cancelled Post Market | |
| RHOTRAL 200 | 01910159 | Cancelled Post Market | |
| RHOTRAL 400 | 01910167 | Cancelled Post Market | |
| RHOTRIMINE | 00761605 | Cancelled Post Market | |
| RHOTRIMINE | 00761613 | Cancelled Post Market | |
| RHOTRIMINE | 00761621 | Cancelled Post Market | |
| RHOTRIMINE | 00761648 | Cancelled Post Market | |
| RHOTRIMINE | 00761656 | Cancelled Post Market | |
| RIFADIN | 02091887 | Cancelled Post Market | |
| RIFADIN | 02092808 | Cancelled Post Market | |
| RIFATER | 02148625 | Cancelled Post Market | |
| RYTHMODAN | 02224828 | Cancelled Post Market | |
| RYTHMODAN-LA | 02224836 | Cancelled Post Market | |
| SECTRAL | 01926543 | Cancelled Post Market | |
| SECTRAL | 01926551 | Cancelled Post Market | |
| SECTRAL | 01926578 | Cancelled Post Market | |
| STEMETIL | 01927795 | Cancelled Post Market | |
| STEMETIL | 01927779 | Cancelled Post Market | |
| SUPRAX | 00868973 | Cancelled Post Market | |
| SURGAM | 02221950 | Cancelled Post Market | |
| SURGAM SR | 02221969 | Cancelled Post Market | |
| SURMONTIL | 01926330 | Cancelled Post Market | |
| SURMONTIL | 01926322 | Cancelled Post Market | |
| TALWIN | 02137984 | Cancelled Post Market | |
| TAMOFEN 10 | 01926624 | Cancelled Post Market | |
| TAMOFEN 20 | 01926632 | Cancelled Post Market | |
| TAXOTERE | 02177099 | Cancelled Post Market | |
| TAXOTERE | 02177080 | Cancelled Post Market | |
| TENUATE | 02047675 | Cancelled Post Market | |
| TENUATE DOSPAN | 02052490 | Cancelled Post Market | |
| TRENTAL | 02221977 | Cancelled Post Market | |
| TUSSIONEX | 01916971 | Cancelled Post Market | |
| TUSSIONEX | 01916963 | Cancelled Post Market | |
| VAPONEFRIN | 01927582 | Cancelled Post Market | |
| VITAMIN A ACID 0.01% CREAM | 01926497 | Cancelled Post Market | |
| VITAMIN A ACID 0.025% CREAM | 01926500 | Cancelled Post Market | |
| VITAMIN A ACID 0.05% CREAM | 01926519 | Cancelled Post Market | |
| VITAMIN A ACID 0.1% CREAM | 01926527 | Cancelled Post Market | |
| ZALTRAP | 02421070 | Cancelled Post Market | |
| ZALTRAP | 02421089 | Cancelled Post Market | |
| ZUACTA | 02354772 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| Pharmaton 50+ | 80043335 | Discontinued | |
| DRISDOL® | 02017598 | Discontinued | |
| Eltor | 02103109 | Discontinued |
Medical device licences
Active licences first, newest first.
| Name | Licence | Status | First licensed |
|---|---|---|---|
| JUNIORSTAR | 92390 | Issued (active) · Class 2 | |
| MYSTAR SYLKFEEL - LANCING DEVICE | 93113 | Discontinued at renewal · Class 2 | |
| MYSTAR SYLKFEEL - LANCETS | 93114 | Discontinued at renewal · Class 2 | |
| IBGSTAR BLOOD GLUCOSE MONITORING SYSTEM | 88072 | Discontinued at renewal · Class 3 | |
| BGSTAR | 86476 | Discontinued at renewal · Class 2 | |
| BGSTAR BLOOD GLUCOSE MONITORING SYSTEM | 86398 | Discontinued at renewal · Class 3 | |
| BGSTAR CONTROL SOLUTION, NORMAL | 86365 | Discontinued at renewal · Class 3 | |
| BGSTAR BLOOD GLUCOSE TEST STRIPS | 86366 | Discontinued at renewal · Class 3 | |
| BGSTAR LANCING DEVICE | 86360 | Discontinued at renewal · Class 2 | |
| LOVENOX HOME CARE KIT | 32371 | Discontinued at renewal · Class 2 |
Notices of Compliance
Newest first.
- DUPIXENTOctober 6, 2026 · NOC 38414 · Supplement to a New Drug Submission (SNDS)
- DUPIXENTSeptember 23, 2026 · NOC 38334 · Supplement to a New Drug Submission (SNDS)
- SARCLISA SCSeptember 15, 2026 · NOC 38284 · Supplement to a New Drug Submission (SNDS)
- FLAGYLAugust 27, 2026 · NOC 38204 · Supplement to a New Drug Submission (SNDS)
- FLAGYSTATINAugust 21, 2026 · NOC 38161 · Supplement to a New Drug Submission (SNDS)
- LEMTRADAAugust 18, 2026 · NOC 38135 · Supplement to a New Drug Submission (SNDS)
- TZIELDJuly 20, 2026 · NOC 37935 · Supplement to a New Drug Submission (SNDS)
- PRALUENTJuly 20, 2026 · NOC 37936 · Supplement to a New Drug Submission (SNDS)
- SARCLISAJune 10, 2026 · NOC 37684 · Supplement to a New Drug Submission (SNDS)
- RENVELAApril 17, 2026 · NOC 37361 · Supplement to a New Drug Submission (SNDS)
- GLUCOPHAGEApril 7, 2026 · NOC 37268 · Supplement to a New Drug Submission (SNDS)
- TOUJEO DOUBLESTARMarch 16, 2026 · NOC 37119 · Supplement to a New Drug Submission (SNDS)
- DUPIXENTMarch 5, 2026 · NOC 37161 · Supplement to a New Drug Submission (SNDS)
- ARAVAFebruary 19, 2026 · NOC 36934 · Supplement to a New Drug Submission (SNDS)
- AVAPROFebruary 18, 2026 · NOC 36930 · Supplement to a New Drug Submission (SNDS)
- FLAGYLFebruary 11, 2026 · NOC 36889 · Supplement to a New Drug Submission (SNDS)
- XENPOZYMEFebruary 4, 2026 · NOC 36855 · Supplement to a New Drug Submission (SNDS)
- THYMOGLOBULINJanuary 22, 2026 · NOC 36784 · Supplement to a New Drug Submission (SNDS)
- PLAQUENILJanuary 16, 2026 · NOC 36741 · Supplement to a New Drug Submission (SNDS)
- PRIMAQUINEJanuary 9, 2026 · NOC 36708 · Supplement to a New Drug Submission (SNDS)
- ALTUVIIIOJanuary 6, 2026 · NOC 36684 · Supplement to a New Drug Submission (SNDS)
- IMOVANEDecember 24, 2025 · NOC 36636 · Supplement to a New Drug Submission (SNDS)
- SOLIQUADecember 11, 2025 · NOC 36521 · Supplement to a New Drug Submission (SNDS)
- CALCIMARNovember 13, 2025 · NOC 36368 · Supplement to a New Drug Submission (SNDS)
- DUPIXENTOctober 27, 2025 · NOC 36299 · Supplement to a New Drug Submission (SNDS)
- ALTUVIIIOOctober 21, 2025 · NOC 36221 · Supplement to a New Drug Submission (SNDS)
- DUPIXENTOctober 21, 2025 · NOC 36227 · Supplement to a New Drug Submission (SNDS)
- SOLIQUAOctober 11, 2025 · NOC 36167 · Supplement to a New Drug Submission (SNDS)
- FLAGYLSeptember 25, 2025 · NOC 36060 · Supplement to a New Drug Submission (SNDS)
- FLAGYSTATINSeptember 25, 2025 · NOC 36062 · Supplement to a New Drug Submission (SNDS)
- DUPIXENTAugust 15, 2025 · NOC 35849 · Supplement to a New Drug Submission (SNDS)
- AVAPROJuly 25, 2025 · NOC 35746 · Supplement to a New Drug Submission (SNDS)
- AVALIDEJuly 25, 2025 · NOC 35749 · Supplement to a New Drug Submission (SNDS)
- PRIMAQUINEJune 25, 2025 · NOC 35581 · Supplement to a New Drug Submission (SNDS)
- REZUROCKJune 18, 2025 · NOC 35535 · Supplement to a New Drug Submission (SNDS)
- KEVZARAMay 9, 2025 · NOC 35336 · Supplement to a New Drug Submission (SNDS)
- FLAGYLMay 8, 2025 · NOC 35319 · Supplement to a New Drug Submission (SNDS)
- FLAGYSTATINMay 8, 2025 · NOC 35321 · Supplement to a New Drug Submission (SNDS)
- TZIELDMay 5, 2025 · NOC 35295 · New Drug Submission (NDS)
- CAPRELSAMay 1, 2025 · NOC 35288 · Supplement to a New Drug Submission (SNDS)
- CEREZYMEApril 17, 2025 · NOC 35214 · Supplement to a New Drug Submission (SNDS)
- SARCLISAApril 17, 2025 · NOC 35232 · Supplement to a New Drug Submission (SNDS)
- ALTUVIIIOMarch 26, 2025 · NOC 35079 · New Drug Submission (NDS)
- PLAQUENILFebruary 21, 2025 · NOC 34886 · Supplement to a New Drug Submission (SNDS)
- ARAVAFebruary 12, 2025 · NOC 34827 · Supplement to a New Drug Submission (SNDS)
- XATRALFebruary 11, 2025 · NOC 34818 · Supplement to a New Drug Submission (SNDS)
- SARCLISAJanuary 31, 2025 · NOC 34773 · Supplement to a New Drug Submission (SNDS)
- MYOZYMEDecember 11, 2024 · NOC 34545 · Supplement to a New Drug Submission (SNDS)
- DUPIXENTNovember 18, 2024 · NOC 34439 · Supplement to a New Drug Submission (SNDS)
- ARAVAOctober 21, 2024 · NOC 34239 · Supplement to a New Drug Submission (SNDS)
- ALPROLIXOctober 21, 2024 · NOC 34243 · Supplement to a New Drug Submission (SNDS)
- CEREZYMEOctober 17, 2024 · NOC 34365 · Supplement to a New Drug Submission (SNDS)
- ELOCTATEOctober 11, 2024 · NOC 34205 · Supplement to a New Drug Submission (SNDS)
- MULTAQOctober 1, 2024 · NOC 34109 · Supplement to a New Drug Submission (SNDS)
- IMOVANESeptember 27, 2024 · NOC 34107 · Supplement to a New Drug Submission (SNDS)
- DUPIXENTSeptember 6, 2024 · NOC 33967 · Supplement to a New Drug Submission (SNDS)
- MABCAMPATHAugust 28, 2024 · NOC 33893 · Supplement to a New Drug Submission (SNDS)
- NEXVIAZYMEAugust 16, 2024 · NOC 33829 · Supplement to a New Drug Submission (SNDS)
- LEMTRADAAugust 8, 2024 · NOC 33778 · Supplement to a New Drug Submission (SNDS)
- ELOCTATEJuly 11, 2024 · NOC 33627 · Supplement to a New Drug Submission (SNDS)
- REZUROCKJune 28, 2024 · NOC 33534 · Supplement to a New Drug Submission (SNDS)
- CEREZYMEMay 28, 2024 · NOC 33318 · New Drug Submission (NDS)
- MYOZYMEMay 17, 2024 · NOC 33255 · New Drug Submission (NDS)
- CABLIVIMay 14, 2024 · NOC 33218 · Supplement to a New Drug Submission (SNDS)
- ALDURAZYMEApril 26, 2024 · NOC 33133 · New Drug Submission (NDS)
- MABCAMPATHApril 19, 2024 · NOC 33109 · New Drug Submission (NDS)
- LEMTRADAApril 19, 2024 · NOC 33110 · New Drug Submission (NDS)
- CERDELGAApril 17, 2024 · NOC 33071 · New Drug Submission (NDS)
- AUBAGIOApril 17, 2024 · NOC 33077 · New Drug Submission (NDS)
- THYROGENApril 11, 2024 · NOC 33055 · New Drug Submission (NDS)
- FABRAZYMEApril 8, 2024 · NOC 33063 · New Drug Submission (NDS)
- CAPRELSAApril 5, 2024 · NOC 33018 · New Drug Submission (NDS)
- RENAGELApril 2, 2024 · NOC 32985 · Supplement to a New Drug Submission (SNDS)
- TOUJEO SOLOSTAR/TOUJEO DOUBLESTARMarch 22, 2024 · NOC 32937 · Supplement to a New Drug Submission (SNDS)
- PRALUENTMarch 15, 2024 · NOC 33250 · Supplement to a New Drug Submission (SNDS)
- DUPIXENTMarch 14, 2024 · NOC 32886 · Supplement to a New Drug Submission (SNDS)
- DUPIXENTMarch 12, 2024 · NOC 32866 · Supplement to a New Drug Submission (SNDS)
- XENPOZYMEFebruary 28, 2024 · NOC 32782 · New Drug Submission (NDS)
- MOZOBILFebruary 16, 2024 · NOC 32718 · Supplement to a New Drug Submission (SNDS)
- FERRLECITFebruary 13, 2024 · NOC 32698 · Supplement to a New Drug Submission (SNDS)
- TRURAPIFebruary 12, 2024 · NOC 32684 · Supplement to a New Drug Submission (SNDS)
- LIBTAYOJanuary 19, 2024 · NOC 32573 · Supplement to a New Drug Submission (SNDS)
- SARCLISAJanuary 12, 2024 · NOC 32515 · Supplement to a New Drug Submission (SNDS)
- SARCLISAJanuary 10, 2024 · NOC 32501 · Supplement to a New Drug Submission (SNDS)
- LIBTAYODecember 15, 2023 · NOC 32392 · Supplement to a New Drug Submission (SNDS)
- PLAQUENILDecember 5, 2023 · NOC 32270 · Supplement to a New Drug Submission (SNDS)
- IMOVANESeptember 29, 2023 · NOC 31747 · Supplement to a New Drug Submission (SNDS)
- FLUDARASeptember 14, 2023 · NOC 31618 · Supplement to a New Drug Submission (SNDS)
- FASTURTECAugust 31, 2023 · NOC 31555 · Supplement to a New Drug Submission (SNDS)
- PEDIAPREDAugust 18, 2023 · NOC 31440 · Supplement to a New Drug Submission (SNDS)
- LIBTAYOAugust 15, 2023 · NOC 31447 · Supplement to a New Drug Submission (SNDS)
- SARCLISAAugust 10, 2023 · NOC 31395 · Supplement to a New Drug Submission (SNDS)
- DUPIXENTJuly 12, 2023 · NOC 31201 · Supplement to a New Drug Submission (SNDS)
- ADLYXINEJuly 11, 2023 · NOC 31208 · Supplement to a New Drug Submission (SNDS)
- JEVTANAJune 28, 2023 · NOC 31064 · Supplement to a New Drug Submission (SNDS)
- SOLIQUAJune 28, 2023 · NOC 31073 · Supplement to a New Drug Submission (SNDS)
- DUPIXENTJune 12, 2023 · NOC 30974 · Supplement to a New Drug Submission (SNDS)
- FASTURTECMay 31, 2023 · NOC 30892 · Supplement to a New Drug Submission (SNDS)
- ADMELOGMay 29, 2023 · NOC 30856 · Supplement to a New Drug Submission (SNDS)
- TRURAPIMay 24, 2023 · NOC 30818 · Supplement to a New Drug Submission (SNDS)
The latest 100 of 479.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Limited number of Sarclisa single use vials may have been frozen during shipmentSeptember 25, 2026 · Biologic or vaccine · Product quality · Type I
- TZIELD (teplizumab) and the Risk of Viral ReactivationSeptember 14, 2026 · Biologic or vaccine · New safety information - Adverse reaction - Product safety
- Sanofi-Aventis Avapro Product Recall(2021-06-14)June 14, 2021 · Drugs · Product safety · Type I
- Sanofi-Aventis Avalide Product Recall(2021-06-14)June 14, 2021 · Drugs · Product safety · Type I
- MabCampath (alemtuzumab) - Risk of Haemophagocytic Lymphohistiocytosis, Stroke (including ischaemic and haemorrhagic stroke), and GlomerulonephritisJune 22, 2020 · Drugs · Product safety
- LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular ReactionsOctober 15, 2019 · Drugs · Product safety
- Nasacort Allergy 24hr (2018-11-19)November 19, 2018 · Drugs · Product safety · Type III
- IMOVANE (zopiclone) - New Dosage Recommendations to Minimize the Risk of Next-Day Impairment - For the PublicNovember 19, 2014 · Drugs · Product safety
- IMOVANE (zopiclone) - New Dosage Recommendations to Minimize the Risk of Next-Day Impairment - For Health ProfessionalsNovember 19, 2014 · Drugs · Product safety
- Aubagio (2014-06-09)July 11, 2014 · Drugs · Product safety · Type III
- Myochrysine (2014-03-12)March 21, 2014 · Drugs · Product safety · Type II
- Jevtana (cabazitaxel) - Potential for Medication Errors During Preparation Leading to Overdose - Notice to HospitalsJanuary 10, 2014 · Drugs · Dosage
- Jevtana (cabazitaxel) - Potential for Medication Errors During Preparation Leading to Overdose - For Health ProfessionalsJanuary 10, 2014 · Drugs · Dosage
- Calcimar (Synthetic Salmon Calcitonin-Solution for Injection) - Labelling Changes to the Product Monograph Due to an Increased Risk of Cancer with Long-Term Use - For Health ProfessionalsJuly 31, 2013 · Drugs · Product safety
- Rifadin (rifampin capsules USP) - Voluntary Recall of One Lot Due to Capsules Under Fill Weight - For Health ProfessionalsMarch 19, 2013 · Drugs
- RifadinMarch 19, 2013 · Drugs · Product safety · Type II
- Multaq (dronedarone) - Information on Important Revisions to Product Monograph - For Health ProfessionalsDecember 8, 2011 · Drugs
- Multaq (dronedarone) - Information on Important Revisions to Product Monograph - For Health ProfessionalsDecember 8, 2011 · Drugs
- Multaq (dronedarone) – Information on Important Revisions to Product Monograph – For the PublicDecember 8, 2011 · Drugs
- Pradax (dabigatran etexilate) and Plavix (clopidogrel bisulfate) - Risk of Potential Patient Harm Associated with Brand Name Confusion - For Health ProfessionalsNovember 8, 2011 · Drugs
- Pradax (dabigatran etexilate) and Plavix (clopidogrel bisulfate) – Risk of Potential Patient Harm Associated with Brand Name Confusion – For the PublicNovember 8, 2011 · Drugs
- Plavix (blood thinner): New recommendations for use with proton pump inhibitors (antacids)September 22, 2011 · Drugs
- Multaq (dronedarone) – Information on Increase in Heart-Related Events in Patients with Permanent Atrial Fibrillation – For Health ProfessionalsAugust 4, 2011 · Drugs
- Multaq (dronedarone) - Information on Increase in Heart-Related Events in Patients with Permanent Atrial Fibrillation - For the PublicAugust 4, 2011 · Drugs · Product safety
- Multaq: Health Canada reviewing heart-related riskJuly 21, 2011 · Drugs
- ANZEMET (dolasetron mesylate) - Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias - For Health ProfessionalsApril 28, 2011 · Drugs
- ANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – For the PublicApril 28, 2011 · Drugs
- Multaq (dronedarone) - Updated Safety Information in Regards to Hepatocellular Liver Injury - For Health ProfessionalsMarch 15, 2011 · Drugs
- Multaq (dronedarone) – Updated Safety Information in Regards to Hepatocellular Liver Injury – For the PublicMarch 15, 2011 · Drugs
- Cerezyme (imiglucerase for injection) - Supply and Recommendations for Restarting Cerezyme - For Health ProfessionalsDecember 29, 2009 · Biologic or vaccine
- Archived - Cerezyme (imiglucerase for injection) - Supply and Recommendations for Restarting Cerezyme - For the PublicDecember 29, 2009 · Biologic or vaccine
- Thyrogen (thyrotropin alfa for injection): Caution with Preparation and Administration - For Health ProfessionalsDecember 9, 2009 · Biologic or vaccine
- Cerezyme (imiglucerase for injection), Fabrazyme (agalsidase beta), Myozyme (alglucosidase alfa) and Aldurazyme (laronidase): Caution with Preparation and Administration - For Health ProfessionalsDecember 9, 2009 · Biologic or vaccine
- Important Safety Information on KETEK (telithromycin) - For Health ProfessionalsSeptember 5, 2007 · Drugs
- Important Safety Information on FLUOTIC (sodium fluoride) 20 mg tablets - For Health ProfessionalsJune 27, 2007 · Drugs
- Ketek (telithromycin) - Advisories, Warnings and Recalls for Health ProfessionalsOctober 3, 2006 · Drugs
- Important Safety Information on Anzemet (dolasetron mesylate): New Contraindications - Notice to HospitalsJune 30, 2006 · Drugs
- Archive – Antibiotic Ketek and Possible Association with Liver FailureFebruary 7, 2006 · Drugs
- Archived – ARAVA (Leflunomide) and Lung Inflammation Causing Difficulty Breathing – For the PublicJune 24, 2004 · Drugs · Product safety
- ARAVA (Leflunomide) and Interstitial Lung Disease – For Health ProfessionalsJune 24, 2004 · Drugs · Product safety